全文获取类型
收费全文 | 2523篇 |
免费 | 190篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 110篇 |
妇产科学 | 21篇 |
基础医学 | 334篇 |
口腔科学 | 89篇 |
临床医学 | 238篇 |
内科学 | 453篇 |
皮肤病学 | 46篇 |
神经病学 | 135篇 |
特种医学 | 192篇 |
外科学 | 308篇 |
综合类 | 69篇 |
一般理论 | 2篇 |
预防医学 | 244篇 |
眼科学 | 172篇 |
药学 | 112篇 |
中国医学 | 2篇 |
肿瘤学 | 190篇 |
出版年
2020年 | 18篇 |
2019年 | 25篇 |
2018年 | 37篇 |
2017年 | 22篇 |
2016年 | 23篇 |
2015年 | 42篇 |
2014年 | 45篇 |
2013年 | 75篇 |
2012年 | 103篇 |
2011年 | 102篇 |
2010年 | 77篇 |
2009年 | 56篇 |
2008年 | 93篇 |
2007年 | 135篇 |
2006年 | 100篇 |
2005年 | 79篇 |
2004年 | 85篇 |
2003年 | 73篇 |
2002年 | 79篇 |
2001年 | 72篇 |
2000年 | 92篇 |
1999年 | 70篇 |
1998年 | 47篇 |
1997年 | 47篇 |
1996年 | 55篇 |
1995年 | 44篇 |
1994年 | 39篇 |
1993年 | 33篇 |
1992年 | 38篇 |
1991年 | 50篇 |
1990年 | 45篇 |
1989年 | 77篇 |
1988年 | 66篇 |
1987年 | 46篇 |
1986年 | 45篇 |
1985年 | 51篇 |
1984年 | 27篇 |
1983年 | 42篇 |
1982年 | 24篇 |
1981年 | 27篇 |
1980年 | 38篇 |
1979年 | 33篇 |
1978年 | 28篇 |
1977年 | 30篇 |
1976年 | 26篇 |
1975年 | 30篇 |
1974年 | 24篇 |
1973年 | 26篇 |
1972年 | 19篇 |
1966年 | 17篇 |
排序方式: 共有2731条查询结果,搜索用时 0 毫秒
1.
Newell W JohnsonEditor 《Oral diseases》2005,11(1):2-2
The following declaration was agreed by all participants at the conclusion of the 5th World Workshop on Oral Health and Disease in AIDS. It is reproduced here to draw attention to the world's oral health scientists, and others, of the burden that oral disease causes to those who are HIV positive, and to the important role of the dental and allied oral health professions in caring for these individuals and in the research which will underpin improved understanding and care. 相似文献
2.
Single-antibiotic use for penetrating abdominal trauma 总被引:1,自引:0,他引:1
R M Nelson P R Benitez M A Newell R F Wilson 《Archives of surgery (Chicago, Ill. : 1960)》1986,121(2):153-156
A prospective randomized study compared the use of moxalactam disodium vs clindamycin phosphate and tobramycin sulfate for treatment of 190 patients with penetrating abdominal trauma. Twenty-seven patients were disqualified because of early death or failure to follow the protocol. The patients in each group were comparable regarding the cause and severity of injury. No significant difference was seen in the incidence of intra-abdominal infection between the moxalactam-treated group (13%) and the clindamycin- and tobramycin-treated group (9%). The intra-abdominal infection rate in patients with colon injuries (21%) was significantly increased when compared with the patients without colon injuries (6%), but the antibiotic regimen did not significantly change the infection rate. No evidence of bleeding problems from moxalactam were noted. Changes in prothrombin and partial thromboplastin times appeared to be related to shock rather than the use of moxalactam. The most severe coagulopathies occurred prior to moxalactam therapy and were seen only in those patients who had shock requiring 10 or more units of blood. Moxalactam is as effective as combination (clindamycin and tobramycin) antimicrobial therapy in patients with penetrating abdominal trauma. 相似文献
3.
The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data 总被引:1,自引:0,他引:1
The accuracy of historical information derived from self-administered questionnaires must be confirmed. We report the results of studies conducted to assess the reliability and validity of data collected from a comprehensive cancer risk factor questionnaire developed at The University of Texas M.D. Anderson Cancer Center. A comparison of the basic demographic data of a randomly selected sample of 80 respondents and 70 nonrespondents revealed no fundamental ethnic or socioeconomic differences. We verified self-reported past illnesses, surgical procedures, and cancers by reviewing 72 patient charts, using stringent diagnostic criteria for verification. We noted substantial agreement between self-reported and documented illnesses and operations. With the exception of nine patients who misclassified metastatic disease, the verification of primary cancers was excellent. We determined reliability by interviewing 50 of these patients by telephone. Questions with a dichotomous outcome (e.g., smoking status) were reliably answered; however, those requiring quantification (e.g., amount of alcohol consumed) were less accurately reported on interview. While we recognize the limitations of self-administered questionnaires, we believe this program will develop into a comprehensive, standardized, easily accessible patient risk factor data base. 相似文献
4.
Critically ill patients often demonstrate that whole body oxygen consumption (VO2) is dependent on oxygen delivery (DO2). In this retrospective study, the relationship of VO2 to DO2 in patients with isolated head injury (HI, n = 18) was compared to that in patients with multiple trauma (MT, n = 60) without serious head injury. Mean pulmonary capillary wedge pressure, central venous pressure, arterial PCO2, cardiac index, and oxygen delivery were significantly lower in HI, but oxygen consumption was not different in the groups. In both groups, changes in DO2 (delta DO2) within each patient were significantly correlated with changes in VO2 (delta VO2) in that same patient. This relationship was not different between the HI patients, (delta VO2 = (0.20 +/- 0.02) delta DO2), and the MT patients (delta VO2 = (0.17 +/- 0.01) delta DO2). When these groups were further divided into those with high hematocrit (greater than 32%) and low hematocrit (less than 32%), HI patients with a low hematocrit demonstrated a steeper regression slope, with 26 +/- 3% of the DO2 change being reflected in the VO2 change. This was significantly greater than the slope in HI patients with high hematocrit (13 +/- 3%) and the MT patients at high (19 +/- 2%) or low (16 +/- 2%) hematocrits. These data show a correlation between changes in oxygen delivery and consumption that is similar in both head-injury patients and multiple trauma patients without serious head injury. This relationship was greatest in head-injured patients at low hematocrit. This relationship of VO2 and DO2 in both groups suggests an influence of neurohumoral factors rather than local tissue phenomena.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
5.
6.
Patients with xeroderma pigmentosum (XP) have defective DNA repair and a high predisposition to developing abnormalities and neoplasia in the sun-exposed areas of the skin and mucous membranes. The most common tumors reported in patients with XP are squamous cell carcinomas, basal cell carcinomas, and melanomas. Atypical fibroxanthoma (AFX) is a pleomorphic tumor that arises predominantly in the sun-damaged skin of the head and neck regions of the elderly. We describe a unique case of a 6-year-old African American boy with XP who developed an atypical fibroxanthoma and 2 squamous cell carcinomas in the conjunctiva. The clinical and histopathologic findings of AFX are discussed. 相似文献
7.
The plasma, urinary and biliary clearances of cisplatin and its non-nephrotoxic analogue, Carboplatin (cis-diammine-1,1-cyclobutane dicarboxylate platinum II, CBDCA, JM8) have been determined in mice and rats following intravenous administration of the compounds. The plasma concentration-time curves were biphasic during the time period studied (0-60 min), with t1/2 alpha of 2-3 min for both platinum complexes and t1/2 beta of 10-15 min for cisplatin and 25-26 min for Carboplatin. The kinetic rate constants, k12 and k21, were similar for both Carboplatin and cisplatin, indicating that there was no appreciable net accumulation of the compounds in the peripheral tissues. Immediately after administration, Carboplatin became reversibly bound to plasma proteins in vivo to the extent of about 20%. Appreciable irreversible binding appeared after the first 60 min and increased steadily, so that by 4 hr only 34% of the compound was present in the plasma as the free drug. In comparison, binding of cisplatin to plasma was exclusively irreversible and, after the first 10 min, free drug disappeared rapidly, such that by 60 min free platinum was not detectable. The plasma clearance of free cisplatin (26.1 ml/min/kg) was significantly greater than that of either Carboplatin (10.3 ml/min/kg) or insulin (10.1 ml/min/kg). The main route of excretion of the two platinum complexes was via the urine, with 80-90% of Carboplatin and 43-48% of cisplatin being excreted within 4 hr. In the rat, the Carboplatin excreted in the urine was predominantly as the unchanged compound. The renal clearance of cisplatin (12.3 ml/min/kg) was significantly greater than that of either Carboplatin (9.3 ml/min/kg) or insulin (9.6 ml/min/kg), suggesting that cisplatin was excreted by an active renal secretory mechanism whilst Carboplatin was eliminated by glomerular filtration alone. Biliary excretion of the two compounds was only 0.4-1.2% of the administered dose in 6 hr, with biliary clearance of cisplatin (0.27 ml/min/kg) being fivefold greater than that of Carboplatin (0.053 ml/min/kg). The results indicate that the major pharmacokinetic differences between Carboplatin and cisplatin relate to their renal handling and their reactivity with macromolecules. These differences may well underline the substantial lack of Carboplatin nephrotoxicity in comparison with cisplatin. 相似文献
8.
Screening for early ovarian cancer 总被引:5,自引:0,他引:5
9.
10.
J W Studd M M Dooley C C Welch K Vijayakanthan J M Mowat A Wade M Newell 《Current medical research and opinion》1989,11(8):477-484
A multi-centre, randomized, single-blind, parallel-group clinical trial was undertaken in 50 patients (26 fenticonazole, 24 clotrimazole) with symptomatic vaginal candidiasis to compare the antifungal efficacy and tolerability of single-dose intra-vaginal treatment with a fenticonazole ovule (600 mg) or a clotrimazole vaginal tablet (500 mg). Assessment was by laboratory mycological investigation and symptomatic assessments for a period of 3 weeks from the day of treatment. Of the 50 patients, 43 (23 fenticonazole, 20 clotrimazole) returned for assessment 1 week after drug administration and 32 (17 fenticonazole, 15 clotrimazole) were re-assessed 3 weeks after drug administration. Both treatments resulted in very similar and highly significant improvements in symptoms, associated with disappearance of detectable Candida in approximately 70% of patients. There were no significant differences between treatments and no appreciable incidence of relapse during the 3-week period of observation. At the end of this period, 10 (59%) of 17 fenticonazole patients were totally disease-free, as compared with 10 (67%) of 15 patients after clotrimazole treatment. The cure rate observed was somewhat less than that previously seen when intra-vaginal cream formulations of the same two drugs were given on a multiple-dose basis. Both drugs were very well tolerated, with no reports of appreciable local or systemic adverse reactions to either drug. 相似文献